Legend Biotech LEGN
NASDAQ LEGN
$21.52 -0.23 (-1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Legend Biotech (LEGN) EBT Margin (QoQ) (2019 - 2026)

Analysis

Legend Biotech (LEGN) EBT Margin (QoQ) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,173.00
Mar 31, 2026 -1,097.00
Dec 31, 2025 792.00
Sep 30, 2025 3,457.00
Jun 30, 2025 195.00
Mar 31, 2025 -7,264.00
Dec 31, 2024 9,723.00
Sep 30, 2024 -6,582.00
Jun 30, 2024 5,398.00
Mar 31, 2024 12,114.00
Dec 31, 2023 -11,966.00
Sep 30, 2023 20,606.00
Jun 30, 2023 3,700.00
Mar 31, 2023 18,300.00
Dec 31, 2022 -18,122.00
Sep 30, 2022 130,288.00
Jun 30, 2022 -154,862.00
Mar 31, 2022 98,003.00
Dec 31, 2021 -30,527.00
Sep 30, 2021 -28,632.00